Alterations in thyroid axis are common in depression and subclinical hypothyroidism may predispose to recurrent depressive episodes and resistance to antidepressants. The same normal reference ranges are used in both depressive and non-psychiatric patients to detect hypothyroidism. We hypothesized that in depressive patients, serum TSH (thyrotropin) elevation within the normal reference range ( upper 25th percentile) may be related to patients ' characteristics reflecting the severity of the depressive illness.
Introduction
Depression may be a clinical symptom of primary hypothyroidism which is usually due to autoimmune disease or the destructive therapy of Graves' disease. Alterations in the thyroid axis are common in depression and several clinical symptoms are common to both depression and hypothyroidism (Nemeroff, 1989) . Clini-cal hypothyroidism is rarely associated with depression (Ordas and Labbate, 1995) and the thyroid axis alterations are generally subtle in depressive patients. The absence of the normal nocturnal TSH surge which may result in a lower circadian thyroid hormone secretion (Jackson, 1996 ; Sullivan et al., 1997) may support the view that thyroid axis alterations are of central origin (Nemeroff, 1989) . Subclinical hypothyroidism is characterized by serum concentrations of thyroxine (T4) within the reference range and a raised serum TSH concentration. This condition which increases with age is higher in women than men and has been found to be quite common in people older than 55 yr in community surveys (Bagchi et al., 1990 ; Parle et al., 1991 ; Sawin et al., 1985) . Subclinical hypothyroidism has been observed in 3.5-13.6 % of depressive patients (Gold et al., 1981 ; Joffe and Levitt, 1992 ; Sternbach et al., 1983) . Further, exaggerated TSH responses to TRH (thyrotropin-releasing hormone) occurs more frequently in depressed patients with normal TSH concentrations, although in the upper half of the range considered normal (Kraus et al., 1997) . Subclinical hypothyroidism may predispose to higher frequency of depressive episodes (Haggerty et al., 1993) . Triiodothyronine and T4 have been proposed as adjuvant therapy in non-responders to antidepressants (Bauer et al., 1998 ; Hickie et al., 1996 ; Howland 1993 ; Jackson, 1996 ; Prange, 1996 ; Sullivan et al., 1997) , although the efficacy of such treatments remains controversial.
Several evidences confirm the association of thyroid axis deficiency with depression, and routine screening for thyroid axis alterations has been advised (Szabadi, 1991) . However, only a few studies evaluated the association of clinical characteristics with thyroid status (Kraus et al., 1998 ; Sullivan et al., 1997) . Furthermore, to establish subclinical hypothyroidism in depressive patients, the reference ranges used are based on observations in nonpsychiatric, endocrinological patients with hypothyroidism. It may, however, be hypothesized that more subtle alterations in the thyroid axis may be related to clinical characteristics in depressive patients and that even small elevations in serum TSH levels, usually considered to be within the normal range, may have clinical consequences.
Materials and methods

Subjects
A total of 151 patients meeting DSM-III-R (American Psychiatric Association, 1987) criteria for major depression as their primary diagnosis and necessitating hospitalization were screened in seven hospitals of the Assistance Publique-Ho# pitaux de Paris. Among these patients 97 had serum TSH and serum-free T4 determined within 8 d of commencing hospitalization ; three patients were excluded from the analyses because they were treated with T4 at the time of serum TSH and T4 determinations. Patients were classified for diagnostic criteria by the MINI International Psychiatric Interview (Lecrubier et al., 1997) . Patients with bipolar disorder, pregnancy, and older than 75 yr were not included in the study. Investigators classified patients as responders or non-responders when they were discharged from hospital. Patients were considered as non-responders if they did not respond to one antidepressant and required at least two different types of antidepressant in succession, at doses generally accepted as sufficiently high to elicit a therapeutic response. The mean age of the 94 patients included in data analysis was 44p13 yr ; 66 (70 %) were women, 49 (52 %) were married, 64 (68 %) had recurrent depression and 60 (64 %) patients presented melancholia according to DSM-III-R criteria for major depressive episode melancholic type. The mean duration of major depressive disorder was 7.6p8.5 yr (median 3.7 yr) and that of the current episode 8.3p8.6 months (median 4 months). Twenty (21 %) patients were receiving neuroleptics, 62 (66 %) benzodiazepines, 8 (8.5 %) anxiolytics other than benzodiazepines, and 1 patient was on lithium and another on carbamazepine (2 %). Fifty (53 %) patients had associated somatic disease conditions. The most frequent somatic illnesses were : hypertension (13 patients) endocrinological disease, mainly diabetes mellitus (7 patients), allergic manifestations (8 patients), and rheumatologic disease conditions (6 patients). None of the patients were treated by drugs known to modify thyroid function and all were free of iode-containing radiopaque agents. Informed written consent was obtained from each patient and the study was approved by the Ethics Committee of the Cochin Hospital, Paris.
TSH and T4 assays
Serum TSH concentration was measured by third generation chemiluminescent assay (Spencer et al., 1990) and serum T4 by BeriLux FT4 solid phase antigen luminescent technique (Behringwerke AG, Marburg, Germany).
Statistical analyses
Serum TSH and serum-free T4 concentrations were determined in seven different centres. There was no difference between the centres for either serum TSH or serum-free T4 concentrations. As normal ranges of each laboratory were somewhat different, TSH data were transformed as percentages of the respective normal ranges of each laboratory. Further, because TSH and T4 data were not normally distributed [especially TSH data which were negatively (left) skewed] data were normalized by logarithmic transformation. Statistical analyses were thus performed on log-transformed data. Normal laboratory ranges for serum TSH (and serum-free T4) are determined to exclude overt hypo-or hyperthyroidism. We hypothesized that in psychiatric conditions more subtle thyroid axis changes may play a role, and dichotomized this population of patients with major depression into two categories : (i) patients who had serum TSH concentrations upper 25th percentile and (ii) those who had serum TSH concentrations upper 25th percentile of the reference range.
Although for age no significant difference occurred, age was included in each statistical analyses as covariate. ANCOVA was used for between-group comparisons of Serum TSH and severity of depression continuous variables. Frequencies were compared by the Mantel-Haenszel χ# test. Stepwise forward logistic regression analysis was used to identify variables associated with serum TSH status. Correspondence analysis was used to identify aggregates of different variables. Statistical analyses were performed by statistical software BMDP (release 7, 1992, Los Angeles, CA). All tests were two-tailed. Differences were considered significant if p 0.05.
Results
Among the 94 patients with major depression only five had serum TSH concentrations higher than the normal reference range and only one had a serum TSH concen- tration twice as high as the upper limit of the reference range. None of the patients had serum-free T4 concentrations beyond the limits of the reference range. Thus, the frequency of subclinical hypothyroidism in this sample was 5.3 %. Table 1 shows the effect of the normal range of serum TSH concentration upper 25th percentile when compared with that upper 25th percentile. Patients who had serum TSH concentrations upper 25th percentile of the normal range, or higher, were more likely to have recurrent depression, longer disease duration, higher number of previous suicide attempts, higher number of episodes of major depression, and higher body mass index. Variables having a p value lower than 0.1 were included in a stepwise age-adjusted logistic re- The relationship between variables can be further illustrated by correspondence analysis. Figure 1 gives projections of the variables on the first two axes and shows that serum TSH concentrations upper 25th percentile of the normal reference range are projected on the upper side of and close to axis 2, along with the following variables : presence of melancholia, presence of Statistical analysis was performed on log-transformed data. * p 0.05, ** p 0.01, *** p 0.0001 somatic disease condition, recurrence of depressive episodes, prescription of at least two antidepressants, presence of severe major depressive episodes and a previous history of a suicide attempt. When serum-free T4 and TSH levels were directly compared according to several characteristics of the depressive illness, a higher serum TSH concentration was observed in patients with recurrent depression, melancholia and associated psychiatric and somatic disease conditions. Patients with other associated psychiatric diagnoses also had a lower serum-free T4 concentration ( Table 2 ). The presence of associated generalized anxiety disorder (n l 29) did not influence serum-free T4 (12.4p2.6 vs. 13.9p2.9 pmol\l, p l 0.25) or serum TSH (1.5p0.9 vs. 1.5p1.2 pmol\l, p l 0.57) concentrations.
Discussion
This study shows that ' high-normal ', i.e. upper 25th percentile of the normal range of serum TSH concentration is associated with greater severity of major depression. According to multivariate analyses, depressive patients with ' high-normal ' TSH concentrations were more likely to have recurrent depression, previous suicide attempts, associated somatic and psychiatric disease conditions, melancholia and were treated by two or more antidepressants than those with ' low-normal ' ( upper 25th percentile of the normal range) serum TSH concentrations.
The relationship between reduced thyroid axis function and depression has long been suspected. However, overt hypothyroidism is very rare among depressive patients (Fava et al., 1995 ; Gold et al., 1981) . No specific study compared the prevalence rate of subclinical hypothyroidism among depressive patients with that in the general population. However, prevalence rates seem to be similar : subclinical hypothyroidism has been observed in 3.5-13.6 % of depressive patients (Gold et al., 1981 ; Joffe and Levitt, 1992 ; Sternbach et al., 1983) and it is estimated to be 5.6-11.1 % for women and 2.7-3.7 % for men between the age range of 35 and 65 yr in the normal population (Danese et al., 1996) . Subclinical hypothyroidism increases with age and is approximately twice as frequent among women than among men (Bagchi et al., 1990 ; Parle et al., 1991) as is the prevalence of depression.
The definition of subclinical hypothyroidism is based on the normal reference range of serum TSH concentrations. This reference range has been established in healthy subject populations (generally blood donors) without clinical signs of endocrinological thyroid dysfunction. It is not known whether this ' endocrinological ' reference range can be applied to patients with depression. Recent studies suggest that ' high-normal ' serum TSH concentration is associated with exaggerated TSH response to TRH in depressed patients (Kraus et al., 1997) . Circadian difference in serum-free T4 concentration distinguishes between depressed and control subjects ; depressed subjects have a higher mean TSH response to TRH than those with single episodes (Sullivan et al., 1997) . It seems, therefore, that subtle thyroid underfunction, with serum TSH concentrations in the upper third or quarter of the usual ' endocrinological ' reference range may be a contributory factor in patients with depression. A similar phenomenon has been found for high serum cholesterol levels. In persons with high serum cholesterol concentration T4 administration significantly reduced total and LDL-cholesterol only in subjects with ' high-normal ' serum TSH concentrations and it had no effect in those persons who had ' low-normal ' serum TSH levels (Michalopoulou et al., 1998) .
Subtle thyroid axis modifications may account for up to 36 % of the variance in antidepressant treatment outcome (Sullivan et al. 1997) . Tricyclic antidepressant nonresponders have a higher TSH response to TRH and a greater reduction in morning to evening difference in serum T4 levels (Sullivan et al., 1997) . Alterations in thyroid function may influence not only central β-adrenergic (Whybrow and Prange, 1981) but also sero-tonergic activities (Cleare et al., 1995) and this may lead to reduced treatment response. In further studies assessing predictors of antidepressant response, serum TSH concentration should be included as a putative factor which may contribute to treatment response.
Screening for mild thyroid failure and subsequent treatment with levothyroxine sodium is cost-effective because it lowers both hypercholesterolaemia and the risk of cardiovascular disease, and progression toward overt hypothyroidism (Danese et al., 1996) . Similarly, screening for mild thyroid failure including ' high-normal ' serum TSH concentrations may be a cue to the clinician to consider whether such patients have a more severe form of depression. Our findings also suggest that it would be useful to study whether adjunctive treatment with levothyroxine sodium may be beneficial for such patients when they fail to respond to antidepressants.
